Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast for Moderate to Severe Chronic Hand Dermatitis
NCT03741933Phase 4Withdrawn
- Sponsor
- George Washington University
- Start
- Feb 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast in chronic hand dermatitis (CHE), sponsored by George Washington University. Planned start Feb 2019; status: withdrawn.
02
Drugs
apremilast
03
Conditions
chronic hand dermatitis (CHE)
Beyond the preview
Go deeper on NCT03741933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03741933.